The latest installment of the highly regarded "This Week in Virology" (TWiV) podcast, episode 1285, offers a comprehensive review of…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Public Health Data
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…
Read More
TWiV 1287: Ancient Herpesviruses and Modern Dementia
This Week in Virology (TWiV) podcast episode 1287, released on January 11, 2026, delved into two significant scientific inquiries: the…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Vaccine Policy and Ongoing Public Health Challenges
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound concern…
Read More
TWiV 1289: Building a better hepatitis B trap
This Week in Virology (TWiV) episode 1289 delves into two significant advancements in virology: the intricate mechanisms by which the…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In a comprehensive clinical update shared on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, a seasoned clinician…
Read More
TWiV 1291: A foot in the door for cytomegalovirus
The latest episode of "This Week in Virology" (TWiV), episode 1291, delves into two significant advancements in virology: the emergence…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
In a stark assessment of the current state of public health in the United States, Dr. Daniel Griffin, a seasoned…
Read More
TWiV 1293: The enemy of your parasite is your friend
On February 1, 2026, the podcast "This Week in Virology" (TWiV) released its 1293rd episode, delving into two significant scientific…
Read More
Biogen Acquires RayThera for Up to $1 Billion to Bolster Immunology Pipeline
Biogen Inc. has announced a definitive agreement to acquire RayThera, a privately held biotechnology company focused on developing small-molecule therapies…
Read MoreYOU MAY HAVE MISSED
